Advertisement

European Archives of Paediatric Dentistry

, Volume 8, Issue 4, pp 215–218 | Cite as

The Dental Management of five paediatric patients with a history of Acute Intermittent Porphyria

  • E. McGovernEmail author
  • P. Fleming
  • A. O’Marcaigh
Article

Abstract

Background: Acute Intermittent Porphyria (AIP) is a rare autosomal dominant metabolic disorder resulting from partial deficiency of porphobilinogen deaminase, the third enzyme of the haem synthetic pathway. Patients with AIP may be vulnerable to acute neurovisceral attacks if exposed to certain drugs, including some drugs used in dental practice. Case reports: This article outlines the dental management f 5 children with a diagnosis of latent AIP or a family history of AIP. The local analgesic agent used in all cases was bupivacaine or levobupivacaine. Nitrous oxide and oxygen inhalation sedation was used in 2 cases and general anaesthesia, using propofol, isoflurane with nitrous oxide and oxygen, was used in another case. The dental treatment undertaken included restorations, endodontics and extractions. Conclusion: Dental treatment using bupivacaine or levobupivacaine as local analgesic agents was successfully and safely provided for 5 children with a diagnosis of latent AIP or a family history of AIP

Keywords

Porphyria Paediatric Dental Local Anaesthesia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005 Mar 15; 142(6): 439–50.PubMedGoogle Scholar
  2. Acute Porphyrias. Drugs unsafe for use in acute porphyrias. British National Formulary (BNF) 2006; Section 9.8.2Google Scholar
  3. Badminton MN, Elder GH. Management of acute and cutaneous porphyrias. Int J Clin. Prac. 2002: 56: 272–278Google Scholar
  4. Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet. 1997 May 31; 349(9065): 1613–7.PubMedCrossRefGoogle Scholar
  5. Gorchein A. Drug treatment in acute porphyria. Br J Clin Pharmacol. 1997 Nov; 44(5): 427–34.PubMedCrossRefGoogle Scholar
  6. Kauppinen R. Porphyrias. Lancet. 2005 Jan 15–21; 365(9455): 241–52.PubMedGoogle Scholar
  7. McNeill MJ, Bennet A. Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth. 1990 Mar; 64(3): 371–3PubMedCrossRefGoogle Scholar
  8. The European Porphyria Initiative (EPI). Information about drugs and porphyria. At: www.porphyria-europe.com (2007)

Copyright information

© European Archives of Paediatric Dentistry 2007

Authors and Affiliations

  1. 1.Dental DepartmentOur Lady’s Children’s HospitalCrumlin, Dublin 12Ireland
  2. 2.Dublin Dental School and Hospital, Trinity CollegeDublinIreland
  3. 3.Department of HaematologyOur Lady’s Children’s HospitalCrumlin DublinIreland

Personalised recommendations